An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly improved recurrence risk stratification in hormone receptor (HR)-positive, ...

At baseline, approximately 92% of patients were MRD-negative and had excellent outcomes, with a 5-year distant recurrence-free interval (DRFI) of 93%. Measured starting at EOT, MRD-negative patients ...